Conferences
Researchers presented their outstanding research at 38 conferences. The details of their participation are highlighted below.
38
Total number of conferences attended
54
Number of poster submitted
31
Number of oral presentations
38
Total number of abstracts submitted
65
Number of abstracts submitted internationally
20
Number of abstracts submitted nationally
84th Scientific Sessions – American Diabetes Association (ADA)
14
Total number of abstracts presented
60th Annual European Association for the Study of Diabetes (EASD)
2
Total number of oral presentations
List of abstracts presented at the ADA 84th Scientific Sessions and 60th EASD; 2024
| American Diabetes Association (ADA) 84th Scientific Sessions | ||
| # | Title | Type |
| 1 | #4003 Association between PCSK7 Levels and NAFLD Severity in KADEM Study | Poster |
| 2 | Peroxisome Proliferator-Activated Receptor Delta (PPARδ)—A Key Modulator in the Pathogenesis of Diabetes Mellitus and Mycobacterium Tuberculosis Comorbidity | Poster |
| 3 | Early Aged Mice Stay Metabolically Stable with High-Fat Diet. | Poster |
| 4 | Sunflower Oil HFD Feeding in Mice Leads to Gut Dysbiosis, Mild Steatohepatitis, and Impaired Glycemic Control. | Poster |
| 5 | Role of HLA class I gene alleles and haplotypes in type 1 diabetes in Kuwaiti children. | Poster |
| 6 | Actionable Pharmacogenomic Variants in the Kuwaiti Population | Poster |
| 7 | Detection of Potential Therapeutic Target Associated with Coronary Artery Disease in Type 2 Diabetes Patients—System Biology Approach | Poster |
| 8 | Small RNA-seq identifies distinct miRNAs involved in familial and sporadic Type 1 diabetes cases from Kuwait. | Poster |
| 9 | The association of timing and magnitude of peak physical activity with cardiometabolic health outcome in people with diabetes | Poster |
| 10 | Four Loci, Four Fates—Differential Regulation of IRF5 Promoter in Prodiabetogenic Stress | Poster |
| 11 | #2736 MiR103 as a Potential Inhibitor for Dyslipidemia through Modulation of ANGPTL8 Level | Oral |
| 12 | #4073 Synergistic Effects of Dapagliflozin and Tirzepatide Combination Treatment on Weight Loss and Glucose Regulation in Diet-Induced Obese Animals | Oral |
| 13 | #3319 Pioglitazone Amplifies the Decrease in HbA1c and Prevents the Increase in Plasma Ketone Caused by Dapagliflozin in Type 1 Diabetes Mellitus Patients | Oral |
| 14 | Sustained TNF-a Transcription Triggered in Obesity through H3K9/K18 Acetylation Is Associated with Metabolic Impairments. | Oral |
| Annual European Association for the Study of Diabetes (EASD; 2024) | ||
| 1 | Adipose Angptl8 controls glucose and energy metabolism and its suppression in mice improves diet induced obesity. | Oral |
| 2 | Dissecting the Causal Association Between Spleen Iron Concentration and Type 2 Diabetes Mellitus Using Two-Sample Mendelian Randomisation | Oral |
